Novel molecular scaffolds produced via a one-pot multicomponent modular synthesis approach, targeting potential agrochemical applications. These unsymmetrical functionalized N-alkyl carboxylic acid imides represent a new class of compounds with tunable properties for crop protection and agricultural chemistry.
This offering presents a novel class of unsymmetrical functionalized N-alkyl carboxylic acid imides designed for potential applications as agrochemicals. The compounds are produced through a chemistry-driven synthesis approach that leverages a one-pot multicomponent modular methodology. This innovative approach generates new molecular scaffolds with structural diversity, opening pathways for developing next-generation crop protection agents, herbicides, fungicides, or plant growth regulators.
The modular nature of the synthesis enables systematic variation of functional groups, allowing researchers to fine-tune physicochemical properties such as solubility, stability, and biological activity. This adaptability makes the compound library a valuable starting point for agrochemical discovery and optimization programs.
Key features:
Synthesis approach:
The one-pot multicomponent methodology combines multiple building blocks in a single reaction vessel, reducing synthesis steps and improving efficiency compared to traditional multi-step approaches. This modular strategy facilitates the generation of compound libraries with diverse substitution patterns.
This technology is at an early research stage. The novel molecular scaffolds have been produced through the described synthesis approach, establishing proof-of-concept for the methodology. Further validation studies, including biological screening, structure-activity relationship analysis, and field testing, would be needed to advance these compounds toward commercial agrochemical applications. The current readiness level supports collaborative research partnerships for compound optimization and efficacy evaluation.
The University of Maryland is the state's flagship public research university in College Park, serving a large student body and offering comprehensive academic and research programs. Industry engages through an adjacent research park, shared prototyping facilities, and dedicated corporate partnership channels, plus joint pathways to a medical campus for clinical and regulatory engagement. Its Washington–Baltimore location places partners near federal agencies, national labs, and prime contractors, while a statewide extension network supports collaboration with companies. Research is backed by competitive federal funding from agencies such as NSF, NIH, DoD, DOE, NASA, and USDA, and coordinated commercialization services advance IP, startup formation, licensing, and industry-sponsored research.